Acuta Capital Partners’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-60,000
| Closed | -$1.48M | – | 50 |
|
|
2021
Q3 | $1.48M | Hold |
60,000
| – | – | 0.52% | 38 |
|
|
2021
Q2 | $1.48M | Sell |
60,000
-22,000
| -27% | -$544K | 0.59% | 33 |
|
|
2021
Q1 | $1.79M | Sell |
82,000
-164,200
| -67% | -$3.58M | 0.64% | 36 |
|
|
2020
Q4 | $6.28M | Buy |
246,200
+11,200
| +5% | +$286K | 1.71% | 24 |
|
|
2020
Q3 | $6.62M | Buy |
235,000
+117,500
| +100% | +$3.31M | 1.8% | 20 |
|
|
2020
Q2 | $3.32M | Buy |
+117,500
| New | +$3.32M | 0.96% | 35 |
|